NIH-funded research R01 grant

Understanding How E-cigarette Policies Affect Youth Tobacco Use

Official title: Evaluating the Effect of E-cigarette Policies on Youth Tobacco Use

Funded at University of Missouri-Columbia · NIH-11160425 · Data updated 2026-11-12

This project looks at how different rules about e-cigarettes, like flavor bans and age limits, influence whether young people use e-cigarettes and other tobacco products.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startJune 1, 2018
Project endJune 30, 2027
Funding year2025
Award (this year)$514,213
NIH project number5R01DA045016-09
Project IDNIH-11160425 on NIH RePORTER

Who could benefit from this research

Could help

This research primarily benefits young people and adolescents who are current or potential users of e-cigarettes and other tobacco products.

Less likely to help

Individuals who are not young people or those not affected by tobacco policies would not directly benefit from this specific policy research.

What this research studies

We are exploring how policies such as flavor bans, Tobacco 21 laws, and e-cigarette taxes impact young people's choices regarding e-cigarettes and traditional tobacco. By analyzing existing large datasets, we aim to understand if these policies successfully reduce youth e-cigarette use or if they lead to unintended consequences, like switching to other tobacco products. Our goal is to provide clear information that can help shape better regulations to protect youth health.

Why it matters

Potential benefit: If successful, this work could lead to more effective policies that reduce youth tobacco use and improve public health.

How similar studies have gone: Similar quasi-experimental methods have been successfully used in other public health policy analyses to understand population-level effects.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Pesko, Michael — University of Missouri-Columbia
  • Study coordinator: Pesko, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.